From: A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
2019 | |
Subject cognitive decline | |
2018 | |
Resilience in dementia | |
2015 | |
Innate immunity in Alzheimer’s disease | |
The impact of acute and chronic medical disorders on accelerated cognitive decline | |
2014 | |
Cerebral multi-morbidity of the aging brain | |
Lewy body dementia | |
2013 | |
Immunotherapy in Alzheimer’s disease | |
Tau-based therapeutic strategies | |
Abeta catabolism | |
Traumatic brain injury | |
Cognitive enhancers for ageing and Alzheimer’s disease | |
Peripheral biomarkers | |
2012 | |
The new FTD mutation on chromosome 9 | |
2011 | |
Early-onset dementia | |
Amyloid Imaging | |
2010 | |
Failed clinical trials | |
Prevention trials |